<i>Young Women with Locally Advanced Breast Cancer Who Achieve Breast Conservation after Neoadjuvant Chemotherapy Have a Low Local Recurrence Rate</i>

Raeshell S. Sweeting(Vanderbilt University Medical Center), Lisa A. Carey(University of North Carolina at Chapel Hill), Michael O. Meyers(University of North Carolina at Chapel Hill), Carey K. Anders(Duke University), Allison M. Deal(Memorial Sloan Kettering Cancer Center), Amy Drobish(University of North Carolina at Chapel Hill), Nancy Klauber‐DeMore(MUSC Hollings Cancer Center)
The American Surgeon
July 1, 2011
10.1177/000313481107700718
Cited by 25

Related Papers

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k